Neutralizing Anti-interferon-γ Autoantibodies: an Ameliorating Factor in COVID-19 Infection?

J Clin Immunol. 2021 Oct;41(7):1531-1535. doi: 10.1007/s10875-021-01102-7. Epub 2021 Jul 26.

¹ Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Wellcome Trust Brenner Building, St. James University, Beckett Street, Leeds, LS9 7TF, UK.
² Department of Clinical Immunology and Allergy, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
³ Laboratorio 2 Inmunologia, FES-Cuautitlán, UNAM, Cuautitlán Izcalli, Mexico.
⁴ Department of Infectious Diseases, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
⁵ Department of Transplant and Cellular Immunology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
⁶ Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.
⁷ Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.
⁸ Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, CB2 2QQ, UK.
⁹ Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Wellcome Trust Brenner Building, St. James University, Beckett Street, Leeds, LS9 7TF, UK. s.savic@leeds.ac.uk.
¹⁰ Department of Clinical Immunology and Allergy, Leeds Teaching Hospitals NHS Trust, Leeds, UK. s.savic@leeds.ac.uk.

^# Contributed equally.

No abstract available

Publication types